Surgical Approach for Acute External Thrombosed Hemorrhoidal Disease
Surgical Excision Versus Medical Treatment in Acute External Thrombosed Hemorrhoidal Disease
1 other identifier
observational
132
1 country
1
Brief Summary
Acute external thrombosed hemorrhoidal disease (AETHH) is one of the emergent complications of hemorrhoidal disease that results in pain and loss of work force. Although surgical excision is recommended in the treatment of AETHH in the guidelines of the American Society of Colorectal Surgeons (ASCRS) and the European Society of Coloproctology (ESCP), the level of evidence is low and it is emphasized that additional studies are needed. Therefore, the investigators aimed to compare the efficacy of surgical excision with medical treatment in the treatment of AETHH.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 14, 2023
CompletedFirst Submitted
Initial submission to the registry
August 17, 2023
CompletedFirst Posted
Study publicly available on registry
August 24, 2023
CompletedAugust 28, 2023
August 1, 2023
6 months
August 17, 2023
August 24, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Pain score with visual analog scale
The participants pain at the 12th hour postoperatively was scored with a visual analog scale. The visual analog scale was between 0 and 10 mm. 0 rated as no pain, 10 as very severe pain.
12 hours
Secondary Outcomes (3)
Time to return to daily activities
15 days
Recurrence
6 months
Satisfaction survey
6 months
Study Arms (2)
Conservative Treatment Group
Micronized purified flavonoid fraction, which is routinely used within indications in hemorrhoidal disease and recommended in ESCP and ASCRS guidelines, and licensed for use in hemorrhoidal disease by the Ministry of Health in our country, was given 2 g/day for one month. Also, Conservative methods (fiber foods, warm shower, regulation of toilet habits, laxatives and nonsteroidal anti-inflammatory drugs) were recommended.
Surgical Treatment Group
While the patient was in the Jack-knife position, both hips were pulled laterally with tapes, appropriate visualization was obtained, the external thrombosed pack was excised under local anesthesia, and the wound was left to heal with secondary intention.Conservative methods were recommended in the surgical group as well as in the medical group.
Interventions
Micronized purified flavonoid fraction, which is routinely used within indications in hemorrhoidal disease and recommended in ESCP and ASCRS guidelines, and licensed for use in hemorrhoidal disease by the Ministry of Health in our country, was given 2 g/day for one month. Also, Conservative methods (fiber foods, warm shower, regulation of toilet habits, laxatives and nonsteroidal anti-inflammatory drugs) were recommended.
While the patient was in the Jack-knife position, both hips were pulled laterally with tapes, appropriate visualization was obtained, the external thrombosed pack was excised under local anesthesia, and the wound was left to heal with secondary intention.Conservative methods were recommended in the surgical group as well as in the medical group.
Eligibility Criteria
The population of the study consisted of patients who applied to the general surgery outpatient clinic due to acute external thrombosed hemorrhoids disease. Patients who fully met the inclusion criteria and did not meet the exclusion criteria constituted the sample group.
You may qualify if:
- Patients between the ages of 18-70 who present with isolated external thrombosed hemorrhoids
- Patients with the onset of the complaint before 96 hours
You may not qualify if:
- Patients under the age of 18 and patients over the age of 70
- Mentally retarded patients
- Pregnant patients
- Patients with concomitant proctological disorders (anal fissure, anal fistula, anal abscess, etc.)
- Those with a history of proctology surgery
- Patients with grade 3-4 internal hemorrhoids
- Patients using anticoagulant drugs
- Patients whose complaint has passed 96 hours after onset
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Konya Training and Research Hospital
Konya, 42090, Turkey (Türkiye)
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hasan Yaldız, MD
Konya City Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principle Investigator
Study Record Dates
First Submitted
August 17, 2023
First Posted
August 24, 2023
Study Start
July 1, 2022
Primary Completion
December 31, 2022
Study Completion
March 14, 2023
Last Updated
August 28, 2023
Record last verified: 2023-08